Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from F5

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022

Financial transformation

Financial transformation

The financial sector is on the cusp of yet another transformation. Customers emerging from Covid-19 are demanding new and better sets of services to meet their new consumption patterns, be it how they shop, eat, work or transfer money. It's a dramatic shift that is compelling banks to transform or…

Here's How Much You Would Have Made Owning F5 Stock In The Last 20 Years

Here's How Much You Would Have Made Owning F5 Stock In The Last 20 Years

F5 (NASDAQ:FFIV) has outperformed the market over the past 20 years by 11.42% on an annualized basis producing an average annual return of 18.59%. Currently, F5 has a market capitalization of $10.21 billion.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: F5 Q2 Earnings

F5 (NASDAQ:FFIV) reported its Q2 earnings results on Tuesday, April 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings F5 beat estimated earnings by 5.97%, reporting an EPS of $2.13 versus an estimate of $2.01.

What 8 Analyst Ratings Have To Say About F5

F5 (NASDAQ:FFIV) has observed the following analyst ratings within the last quarter:

Take Advantage of These 5 'Strong Buy' Stocks Down More Than 10% YTD

Amid deepening supply disruptions and record-high inflation, expected aggressive federal interest rate increases, and the resurgence of COVID-19 cases have been driving market volatility. However, we think quality stocks Agilent (A), Olympus (OCPNY), F5 (FFIV), Jones Lang LaSalle (JLL), and United Therapeutics (UTHR), which are down more than 10% in…

A Bearish Sign Appears On F5's Chart

If history is any guide, there may be trouble ahead for shares of F5 (NASDAQ:FFIV). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

inkl

Read news from The Economist, FT, and more,
with one subscription

Analysts Cut F5 Price Target Following Lack-Lustre Outlook

Analysts Cut F5 Price Target Following Lack-Lustre Outlook

Expert Ratings For F5

Expert Ratings For F5

Over the past 3 months, 8 analysts have published their opinion on F5 (NASDAQ:FFIV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Jan. 26, 2022: HES, FFIV, TXN, LVS, AAPL

Today's 5 Stock Ideas: Hess (HES) - Shares up premarket. The company reported better-than-expected Q4 EPS results. F5 (FFIV) - Shares down premarket. The company issued Q2 sales guidance below

Recap: F5 Q1 Earnings

Recap: F5 Q1 Earnings

F5 (NASDAQ:FFIV) reported its Q1 earnings results on Tuesday, January 25, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

1 2 3

Organisations

US Federal Reserve

SherwinWilliams

B of A Securities

FreeportMcMoRan

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

392,152 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play